Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Lagerqvist

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|May 8, 2009
Long-term safety and efficacy of drug-eluting versus bare-metal stents in SwedenStefan K James, Ulf Stenestrand, Johan Lindbäck, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|November 11, 2024
Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR ReportSaman Saidi-Seresht, Stefan James, David Erlinge, et al.
The American Journal of Medicine|October 28, 2018
Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and PrognosisAnna M Nordenskjöld, Bo Lagerqvist, Tomasz Baron, et al.
Journal of the American College of Cardiology|May 16, 2024
Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes MellitusIrene Santos-Pardo, Mikael Andersson Franko, Bo Lagerqvist, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 2, 2018
Survival and incidence of cardiovascular diseases in participants in a long-distance ski race (Vasaloppet, Sweden) compared with the background populationUlf Hållmarker, Johan Lindbäck, Karl Michaëlsson, et al.
American Heart Journal|June 1, 2002
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudyErik Diderholm, Bertil Andrén, Gunnar Frostfeldt, et al.
Circulation. Cardiovascular Interventions|March 8, 2019
Assessing the Nationwide Impact of a Registry-Based Randomized Clinical Trial on Cardiovascular PracticeSergio Buccheri, Giovanna Sarno, Ole Fröbert, et al.
Clinical Cardiology|November 20, 2010
Long-term results following switch from abciximab to eptifibatide during percutaneous coronary interventionMichael Koutouzis, Bo Lagerqvist, Jonas Oldgren, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2017
Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Per Grimfjärd, Stefan James, Jonas Persson, et al.
Journal of the American College of Cardiology|December 10, 2003
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery diseaseTomas Jernberg, Bertil Lindahl, Agneta Siegbahn, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|May 8, 2009
Long-term safety and efficacy of drug-eluting versus bare-metal stents in SwedenStefan K James, Ulf Stenestrand, Johan Lindbäck, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|November 11, 2024
Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR ReportSaman Saidi-Seresht, Stefan James, David Erlinge, et al.
The American Journal of Medicine|October 28, 2018
Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and PrognosisAnna M Nordenskjöld, Bo Lagerqvist, Tomasz Baron, et al.
Journal of the American College of Cardiology|May 16, 2024
Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes MellitusIrene Santos-Pardo, Mikael Andersson Franko, Bo Lagerqvist, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 2, 2018
Survival and incidence of cardiovascular diseases in participants in a long-distance ski race (Vasaloppet, Sweden) compared with the background populationUlf Hållmarker, Johan Lindbäck, Karl Michaëlsson, et al.
American Heart Journal|June 1, 2002
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudyErik Diderholm, Bertil Andrén, Gunnar Frostfeldt, et al.
Circulation. Cardiovascular Interventions|March 8, 2019
Assessing the Nationwide Impact of a Registry-Based Randomized Clinical Trial on Cardiovascular PracticeSergio Buccheri, Giovanna Sarno, Ole Fröbert, et al.
Clinical Cardiology|November 20, 2010
Long-term results following switch from abciximab to eptifibatide during percutaneous coronary interventionMichael Koutouzis, Bo Lagerqvist, Jonas Oldgren, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2017
Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Per Grimfjärd, Stefan James, Jonas Persson, et al.
Journal of the American College of Cardiology|December 10, 2003
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery diseaseTomas Jernberg, Bertil Lindahl, Agneta Siegbahn, et al.
Pageof 16